147 related articles for article (PubMed ID: 1633722)
1. Efficacy and tolerability of enteric-coated naproxen in the treatment of osteoarthritis and rheumatoid arthritis: a double-blind comparison with standard naproxen followed by an open-label trial.
Bellamy N; Beaulieu A; Bombardier C; Huang S; Kraag G; Ménard HA; Russell AS; Tannenbaum H; Willans M; Campbell J
Curr Med Res Opin; 1992; 12(10):640-51. PubMed ID: 1633722
[TBL] [Abstract][Full Text] [Related]
2. Open-label tolerability study of enteric-coated naproxen in the treatment of osteoarthritis and rheumatoid arthritis.
Bellamy N; Beaulieu A; Bombardier C; Esdaile J; Huang S; Jovaisas AV; Khanna VN; Kraag G; Mehta DM; Ménard HA
Curr Med Res Opin; 1992; 12(10):652-61. PubMed ID: 1633723
[TBL] [Abstract][Full Text] [Related]
3. A double blind study comparing the efficacy and safety of enteric coated naproxen to naproxen in the management of NSAID intolerant patients with rheumatoid arthritis and osteoarthritis. Naproxen EC Study Group.
Caldwell JR; Roth SH
J Rheumatol; 1994 Apr; 21(4):689-95. PubMed ID: 8035394
[TBL] [Abstract][Full Text] [Related]
4. Enteric coated naproxen; a double blind trial comparing the tolerance of enteric coated and standard formulations.
Huskisson EC; Bernstein RM; Coppock JS; Davies PG; Doyle DV; Platt PR; Scott DL; Witherington RH; Wojtulewski JA
Eur J Rheumatol Inflamm; 1992; 12(2):27-30. PubMed ID: 1364935
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of a new controlled-release formulation of naproxen in osteoarthritis and rheumatoid arthritis. Canadian Multicentre Study Group.
Curr Med Res Opin; 1988; 11(1):16-27. PubMed ID: 2898319
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and tolerability of enteric and non-enteric coated naproxen tablets: a double-blind study in patients with osteoarthritis.
Khong TK; Downing ME; Ellis R; Patchett I; Trayner J; Miller AJ
Curr Med Res Opin; 1991; 12(8):540-6. PubMed ID: 1764957
[TBL] [Abstract][Full Text] [Related]
7. Enteric-coated and plain naproxen tablets in osteoarthritis; tolerability and efficacy.
Lehn OF; Jensen ON; Andersen LA; Christensen KA; Solheim L; Barslev J; Mjølstad W; Wiig G; Ibfelt HH; Kjønniksen T
Eur J Rheumatol Inflamm; 1992; 12(2):31-6. PubMed ID: 1364936
[TBL] [Abstract][Full Text] [Related]
8. A longterm endoscopic evaluation of patients with arthritis treated with nabumetone vs naproxen.
Roth SH; Bennett R; Caldron P; Mitchell C; Swenson C; Koepp R
J Rheumatol; 1994 Jun; 21(6):1118-23. PubMed ID: 7932425
[TBL] [Abstract][Full Text] [Related]
9. Diflunisal versus naproxen in the management of rheumatoid arthritis.
Osborn TG; Parks RL; Moore TL; Grisanti MW; Nesher G; Caciolo BA
Clin Ther; 1989; 11(6):736-43. PubMed ID: 2692819
[TBL] [Abstract][Full Text] [Related]
10. Naproxen tolerability in the elderly: a summary report.
Geczy M; Peltier L; Wolbach R
J Rheumatol; 1987 Apr; 14(2):348-54. PubMed ID: 3599004
[TBL] [Abstract][Full Text] [Related]
11. Double-blind multicentre UK hospital studies of isoxicam vs naproxen.
Cardoe N; Hart FD
Br J Clin Pharmacol; 1986; 22 Suppl 2(Suppl 2):167S-172S. PubMed ID: 3620277
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of nimesulide in elderly patients with osteoarthritis: double-blind trial versus naproxen.
Fossaluzza V; Montagnani G
J Int Med Res; 1989; 17(3):295-303. PubMed ID: 2670634
[TBL] [Abstract][Full Text] [Related]
13. Gastroscopic findings after treatment with enteric-coated and plain naproxen tablets in healthy subjects.
Trondstad RI; Aadland E; Holler T; Olaussen B
Scand J Gastroenterol; 1985 Mar; 20(2):239-42. PubMed ID: 3887555
[TBL] [Abstract][Full Text] [Related]
14. Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo.
Bensen WG; Zhao SZ; Burke TA; Zabinski RA; Makuch RW; Maurath CJ; Agrawal NM; Geis GS
J Rheumatol; 2000 Aug; 27(8):1876-83. PubMed ID: 10955327
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis.
Lister BJ; Poland M; DeLapp RE
Am J Med; 1993 Aug; 95(2A):2S-9S. PubMed ID: 8356999
[TBL] [Abstract][Full Text] [Related]
16. [Results of an open study and a controlled comparative study of feprazone and naproxen in patients with rheumatoid arthritis or osteoarthrosis (author's transl)].
Crone M; Geimer R
Wien Med Wochenschr; 1981 Dec; 131(23-24):597-601. PubMed ID: 7039147
[TBL] [Abstract][Full Text] [Related]
17. Endoscopy-controlled study of the safety of nabumetone compared with naproxen in arthritis therapy.
Roth SH
Am J Med; 1987 Oct; 83(4B):25-30. PubMed ID: 3318424
[TBL] [Abstract][Full Text] [Related]
18. Valdecoxib is associated with improved dyspepsia-related health compared with nonspecific NSAIDs in patients with osteoarthritis or rheumatoid arthritis.
Rabeneck L; Goldstein JL; Vu A; Mayne TJ; Rublee DA
Am J Gastroenterol; 2005 May; 100(5):1043-50. PubMed ID: 15842577
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy and safety of nabumetone in rheumatoid arthritis and osteoarthritis.
Fleischmann RM
J Rheumatol Suppl; 1992 Nov; 36():32-40. PubMed ID: 1474533
[TBL] [Abstract][Full Text] [Related]
20. [Effect and tolerance of naproxen. Testing of a new Galenic preparation of an anti-rheumatic agent in an open clinical trial].
Gaismayer K; Tausch G
Fortschr Med; 1984 Jun; 102(21):601-3. PubMed ID: 6469162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
